Tiger Brokers

  • Quotes
  • Invest
  • Pricing
  • Download
  • Rewards
  • Help
  • TigerAI
  • Institution
    • Wealth and asset manager
    • Proprietary trading institutions
    • Introducing brokers
    • Third-party service provider
    • Esop
  • About
    • About us
    • Newsroom
    • Awards
  • LOGIN
  • SIGN UP
US StockDetailed Quotes
Provided by Tiger Trade Technology Pte. Ltd.

Ultragenyx Pharmaceutical

13.03
-0.0400-0.31%
Volume:394.42K
Turnover:5.17M
Market Cap:1.28B
PE:-2.24
High:13.22
Open:13.07
Low:13.01
Close:13.07
52wk High:39.89
52wk Low:12.88
Shares:98.32M
Float Shares:80.72M
Volume Ratio:0.79
T/O Rate:0.49%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.8279
EPS(LYR):-5.8316
ROE:-608.47%
ROA:-24.22%
PB:-4.40
PE(LYR):-2.23

Loading ...

OverviewCompanyNewsFilings

Analysts Offer Insights on Healthcare Companies: Johnson & Johnson (JNJ), Alnylam Pharma (ALNY) and Ultragenyx Pharmaceutical (RARE)

TIPRANKS
·
Mar 25

Why Ultragenyx (RARE) Is Down 14.4% After Positive Phase 3 DTX301 Gene Therapy Results

Simply Wall St.
·
Mar 25

Goldman Sachs Downgrades Ultragenyx Pharmaceutical to Neutral From Buy, Adjusts PT to $25 From $61

MT Newswires Live
·
Mar 24

Ultragenyx downgraded to Neutral from Buy at Goldman Sachs

TIPRANKS
·
Mar 24

Ultragenyx grants 10,839 restricted stock units under employment inducement plan

Reuters
·
Mar 21

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Mar 21

Analyst Rate

Buy
Buy
55.00%
Hold
45.00%
Sell
0.00%

Corporate Actions

Financial Report Announcement
Aug 04, 2026 Post-Mkt
Financial Report Announcement
May 05, 2026 Post-Mkt
Financial Report Announcement
Feb 12, 2026 Post-Mkt
Financial Report Announcement
Jan 12, 2026 Pre-MKt
Financial Report Announcement
Nov 04, 2025 Post-Mkt

Dividend History

no data

No relevant data is available

Valuation Analysis

-2.24
Current
-6.68
Sector Average
100.00%
Historical Percentile
P/E[TTM]
+1 STD
Average
-1 STD
Current
-2.24
Maximum
-2.28
+1 STD
-3.42
Minimum
-18.97
-1 STD
-9.94
Average
-6.68

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10
     
     
     
     
Company Name:
Tiger Trade Technology Pte. Ltd.
Email Address:
dpo@itiger.com
User Agreement|Privacy Policy

Copyright © Tiger Trade Technology Pte. Ltd.

Product offerings in different jurisdictions may vary.

Information contained on this website is general in nature and does not take into account of your investment objectives, financial situation and specific needs. It should not be regarded as an offer to sell, asolicitation to buy, a recommendation or endorsement for any financial product, nor does it constitute an investment forecast, investment return commitments, investment suggestions or other practical operating opinions. Information contained on this website is for reference only and past performance should not be construed as future performance. Investment involves risks. Before you make an investment decision, you should carefully judge and screen whether the information contained on this website is appropriate for your needs, goals and circumstances.

We strive but cannot guarantee the accuracy, completeness, reliability and timeliness of all information on this website, and we are not responsible for any losses caused by the use of or reliance on relevant information.

The products and services offered on the website are subject to applicable laws, regulations and relevant agreements. Please carefully read and agree to the agreements before using our products and services.